Origin Stock

originww.comHealthcareFounded: 2010

Origin allows for the targeted delivery of nitric oxide, produced at the point of therapy from room air, in a vehicle, thermal plasma, which facilitates delivery of the nitric oxide to the specific tissues requiring treatment.

Register for Details

For more details on financing and valuation for Origin, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Origin.

Register Today

Other companies like Origin in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM